EUDA Announces Reverse Stock Split of its Ordinary Shares

Rhea-AI Summary

EUDA Health Holdings (NASDAQ: EUDA) will implement a 1-for-20 reverse stock split, effective at market open on March 23, 2026. The split was approved by the board under British Virgin Islands law and the post-split CUSIP will be G3142E147.

Outstanding shares are expected to convert from approximately 50,307,491 to about 2,515,375 shares. Warrants will be adjusted proportionately: aggregate warrants remain 8,917,250, reducing issuable shares from 4,458,625 to about 222,932, and the warrant exercise price will change from $11.50 (per half-share basis) to $230.00 per warrant. No fractional shares or cash will be issued for fractions; holdings will be rounded up.

Positive

• Outstanding shares reduced to approximately 2,515,375 after 1-for-20 split
• Potential dilution from warrants reduced to ~222,932 issuable shares

Negative

• No cash paid for fractional shares; holders receive rounded shares only
• Warrant exercise economics reset to $230.00, making exercise less likely

News Market Reaction – EUDA

-15.19% 2.2x vol

10 alerts

-15.19% News Effect

+11.1% Peak Tracked

-19.8% Trough Tracked

-$5M Valuation Impact

$25M Market Cap

2.2x Rel. Volume

On the day this news was published, EUDA declined 15.19%, reflecting a significant negative market reaction. Argus tracked a peak move of +11.1% during that session. Argus tracked a trough of -19.8% from its starting point during tracking. Our momentum scanner triggered 10 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $5M from the company's valuation, bringing the market cap to $25M at that time. Trading volume was elevated at 2.2x the daily average, suggesting increased selling activity.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Reverse split ratio: 1-for-20 Pre-split shares: 50,307,491 shares Post-split shares: 2,515,375 shares +5 more

8 metrics

Reverse split ratio 1-for-20 Ordinary shares reverse stock split

Pre-split shares 50,307,491 shares Ordinary shares outstanding before reverse split

Post-split shares 2,515,375 shares Approximate ordinary shares outstanding after reverse split

Pre-split warrant shares 4,458,625 shares Ordinary shares issuable upon exercise of 8,917,250 warrants before split

Warrants outstanding 8,917,250 warrants Aggregate warrants referenced in the article

Pre-split warrant exercise price $11.50 per share Exercise price before reverse split

Post-split warrant shares 222,932 shares Ordinary shares issuable upon exercise of warrants after split

Post-split warrant exercise price $230.00 per share Exercise price after reverse split

Market Reality Check

Price: $0.3986 Vol: Volume 131,104 vs 20-day ...

normal vol

$0.3986 Last Close

Volume Volume 131,104 vs 20-day average 149,616 ahead of the reverse split news. normal

Technical Price at $0.47, trading below 200-day MA of $2.30 and near 52-week low of $0.458.

Peers on Argus

EUDA was down 7.53% while peers showed mixed moves: RFL -8.57%, OMH +2.34%, NYC ...

EUDA was down 7.53% while peers showed mixed moves: RFL -8.57%, OMH +2.34%, NYC +7.17%, others flat. This pattern points to stock-specific dynamics rather than a sector-wide move.

Historical Context

5 past events · Latest: Mar 04 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Mar 04	Warrant repurchase	Positive	-2.7%	Repurchased and cancelled Streeterville warrant, removing up to 2,000,000 share overhang.
Jan 15	Warrant amendment	Negative	-4.2%	Second amendment further reduced warrant exercise and forced-exercise prices with Streeterville.
Jan 13	Convertible loan deal	Positive	-13.9%	Convertible loan up to RMB 6M to fund Shenzhen cGMP upgrade for China platform.
Jan 07	Warrant repricing	Negative	+5.7%	First warrant amendment cut exercise price and forced-exercise trigger for 2,000,000-share warrant.
Dec 30	Platform launch	Positive	+0.0%	Launched China stem cell extraction, cryostorage and clinical platform with large capacity plans.

Pattern Detected

Recent capital-structure and growth updates have often seen negative or muted next-day price reactions, regardless of whether the news reduced dilution risk or supported expansion.

Recent Company History

Over the past few months, EUDA has focused on capital structure and China expansion. On Dec 30, 2025, it launched a nationwide stem cell platform in China. In early Jan 2026, it repeatedly amended a Streeterville warrant, cutting exercise and forced-exercise prices, then on Jan 13 added a RMB 6 million convertible loan to upgrade a Shenzhen cGMP facility. By Mar 4, 2026, EUDA repurchased and cancelled the Streeterville warrant. The newly announced 1-for-20 reverse stock split fits into this broader series of share-structure adjustments.

Market Pulse Summary

The stock dropped -15.2% in the session following this news. A negative reaction despite the mechani...

Analysis

The stock dropped -15.2% in the session following this news. A negative reaction despite the mechanical nature of a 1-for-20 reverse split would fit a pattern where EUDA’s capital-structure actions have often been followed by selling, even when they reduced overhangs. With the stock already near its 52-week low and well below the $2.30 200-day MA before this news, concerns about reverse splits can reinforce existing downside momentum if investors focus on past dilution and financing activity.

Key Terms

reverse stock split, cusip, warrants, exercise price, +2 more

6 terms

reverse stock split financial

"announced that it will implement a reverse stock split of its ordinary shares"

A reverse stock split is when a company reduces the number of its shares outstanding, making each share more valuable. For example, if you own 100 shares worth $1 each, a 1-for-10 reverse split would turn your 100 shares into 10 shares worth $10 each. Companies often do this to boost their stock price and appear more stable to investors.

cusip financial

"The new CUSIP number for EUDA’s ordinary shares following the Reverse Stock Split"

A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.

warrants financial

"the terms of the Company’s warrants will be adjusted in line with the Reverse Stock Split"

Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.

exercise price financial

"each warrant entitling the holder to purchase one-half of one ordinary share at an exercise price of $11.50"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

book-entry form technical

"stockholders of record holding their shares electronically in book-entry form a transaction notice"

A book-entry form is an electronic record showing ownership of securities instead of a paper certificate; think of it like a bank account ledger that notes who owns shares. It matters to investors because it makes buying, selling and transferring securities faster, safer and cheaper by reducing paperwork, loss or forgery risk, and enabling easier settlement through brokers or a central depository.

transfer agent financial

"The Company's transfer agent, Equiniti, is acting as the exchange agent for the Reverse Stock Split"

A transfer agent is a financial service that keeps the official record of who owns a company's shares, handles the buying and selling of those shares on paper or electronically, and issues or cancels stock certificates. Think of it as the company’s records keeper and mailroom combined—investors rely on it to make sure dividends, shareholder mailings, ownership changes, and proxy voting are processed accurately and securely, which protects ownership rights and helps prevent errors or fraud.

AI-generated analysis. Not financial advice.

SINGAPORE, March 19, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore based non-invasive healthcare provider in Asia focused on Singapore, Malaysia and China, today announced that it will implement a reverse stock split of its ordinary shares at a ratio of 1-for-20 (the “Reverse Stock Split”). The Reverse Stock Split was approved by the Company’s Board of Directors in accordance with British Virgin Islands law. The Reverse Stock Split will take effect at market open on March 23, 2026, and the ordinary shares will trade on a post-split basis on the Nasdaq Capital Market under the Company’s existing trading symbol “EUDA” and will continue to trade under that symbol. The new CUSIP number for EUDA’s ordinary shares following the Reverse Stock Split will be G3142E147.

When the Reverse Stock Split becomes effective, the total number of ordinary shares held by each stockholder of the Company will be converted automatically into the number of ordinary shares equal to (i) the number of issued and outstanding ordinary shares held by each such stockholder immediately prior to the Reverse Stock Split, divided by (ii) twenty (20), with such resulting number of shares rounded up to the nearest whole share. As a result, no fractional shares will be issued in connection with the Reverse Stock Split and no cash or other consideration will be paid in connection with any fractional shares that would otherwise have resulted from the Reverse Stock Split.

Currently, the Company has approximately 50,307,491 ordinary shares outstanding. After the Reverse Stock Split, the Company will have approximately 2,515,375 ordinary shares outstanding. Each stockholder’s percentage ownership interest in the Company and proportional voting power will remain unchanged, except for minor changes and adjustments that will result from the treatment of fractional shares. The rights and privileges of the holders of ordinary shares will be substantially unaffected by the Reverse Stock Split.

In connection with the Reverse Stock Split, the terms of the Company’s warrants will be adjusted in line with the Reverse Stock Split so that the number of ordinary shares underlying the warrants will be proportionately reduced, and the exercise price of the warrants will be proportionately increased. Currently, the Company has approximately 4,458,625 ordinary shares issuable upon exercise of an aggregate of 8,917,250 warrants, with each warrant entitling the holder to purchase one-half of one ordinary share at an exercise price of $11.50 per share. After the Reverse Stock Split, the Company would have approximately 222,932 ordinary shares issuable upon exercise of an aggregate of 8,917,250 warrants, with each warrant entitling the holder to purchase one-fortieth of one ordinary share at an exercise price of $230.00 per share.

The combination of, and reduction in, the ordinary shares as a result of the Reverse Stock Split will occur automatically at the effective time of the Reverse Stock Split without any additional action on the part of the Company's stockholders. The Company's transfer agent, Equiniti, is acting as the exchange agent for the Reverse Stock Split and will send stockholders of record holding their shares electronically in book-entry form a transaction notice indicating the number of shares of common stock held after the Reverse Stock Split. Stockholders who hold their shares through a broker, bank, or other nominee will have their positions adjusted to reflect the Reverse Stock Split, subject to their broker, bank, or other nominee's particular processes, and are not expected to be required to take any action in connection with the Reverse Stock Split.  Stockholders holding paper certificates may (but are not required to) send the certificates to the Company’s transfer agent which will issue a new stock certificate reflecting the Reverse Stock Split to each requesting stockholder.

About EUDA Health Holdings Limited

EUDA Health Holdings Limited (NASDAQ: EUDA) is a Singapore-based leading non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia and China. The Company aims to become a market leader in non-invasive and preventive healthcare, with a strategic focus on the fast-growing longevity sector. Our mission is to address the evolving healthcare needs of over 1.8 billion people across the region which is experiencing significant demographic shifts as more than 30% of the population ages rapidly. By offering innovative, accessible, and science-backed health solutions, EUDA is positioned to lead the transformation of regional healthcare from reactive medical treatment to proactive, longevity-focused care. EUDA also runs a Singapore-based property management business.

Forward-Looking Statements

This document may contain forward-looking statements regarding risks and uncertainties. These statements usually use forward-looking words, such as the words “estimates,” “projected,” “expects,” “envisions,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions). These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside EUDA’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. You should not overly rely on forward-looking statements that are only applicable to the date of publication of this document. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Christensen Advisory

Christian Arnell
Phone: +852 2117 0861
Email: christian.arnell@christensencomms.com

FAQ

What is the EUDA (NASDAQ: EUDA) reverse stock split ratio and effective date?

The reverse stock split is a 1-for-20 consolidation, effective at market open on March 23, 2026. According to the company, the split was board-approved under British Virgin Islands law and will not change the ticker symbol.

How many EUDA shares will be outstanding after the March 23, 2026 reverse split?

After the reverse split, EUDA expects approximately 2,515,375 ordinary shares outstanding. According to the company, this converts roughly 50,307,491 pre-split shares on a 1-for-20 basis.

How will EUDA’s warrants be adjusted by the 1-for-20 reverse split?

Warrants will be proportionately adjusted so aggregate warrants remain 8,917,250, reducing issuable shares to about 222,932. According to the company, each warrant will then entitle holders to one-fortieth of a share at an adjusted exercise price of $230.00.

Will EUDA shareholders receive cash for fractional shares from the reverse split?

No, shareholders will not receive cash for fractional shares; fractional results will be rounded up to whole shares. According to the company, no fractional shares will be issued and no cash or other consideration will be paid for fractions.

Will EUDA’s ticker symbol or CUSIP change after the reverse stock split?

EUDA will continue trading under the existing ticker EUDA on Nasdaq; the new CUSIP will be G3142E147. According to the company, trading will resume on a post-split basis at market open on March 23, 2026.

Do EUDA shareholders need to take action for the March 23, 2026 reverse split?

No action is required for most shareholders; positions will be adjusted automatically. According to the company, record holders in book-entry form will receive a transaction notice and brokers will update client positions per their processes.